Ozempic vs Compounded Semaglutide
Ozempic is the FDA-approved branded semaglutide pen for type 2 diabetes (commonly used off-label for weight). Compounded semaglutide is prepared by a 503A/503B pharmacy when branded supply is constrained or a customized dose is provider-reviewed.
Branded Ozempic is appropriate when supply, insurance coverage, and FDA-labeled diabetes indication align.
Compounded semaglutide is appropriate when provider-reviewed metabolic optimization is the goal and a customized titration is clinically indicated.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Is compounded semaglutide the same drug?
It is the same active molecule prepared by a licensed compounding pharmacy under state and federal oversight.
Why not always use branded?
Supply, cost, and titration flexibility frequently make compounded therapy the appropriate provider-reviewed choice.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment